New agreement aims to streamline sponsored clinical trials in NHSBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39023.609676.DB (Published 09 November 2006) Cite this as: BMJ 2006;333:988
- Susan Mayor
Clinical trials in the United Kingdom that are sponsored by the drug industry and involve NHS hospital patients should be able to start more quickly, under a new agreement introduced by the Department of Health this week.
The department claims that its agreement on clinical trials will allow patients faster access to new treatments and save the health service money by streamlining the system for instigating clinical trials.
The revised model clinical trial agreement offers UK health services and drug and biotechnology companies a clear framework to work with when setting up a clinical trial, meaning that trials should be begun faster. It overcomes delays that occurred previously because each site taking part in a clinical trial tended to negotiate an …